| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.21 | 0.06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |